Effective Management of Difficult Surgical Defects Using Tissue-Engineered Skin

Abstract

Background. Graftskin, a bilayered living skin construct, is an effective therapeutic option in the management of chronic venous ulcerations and simple acute surgical excisions. However, it is not routinely used in the management of complicated surgical wound defects. Objective. To determine the effectiveness of graftskin as a therapeutic modality in difficult surgical defects. Methods. Two patients with complex surgical wound defects after Mohs micrographic surgery underwent a single application of graftskin. The engineered skin was fenestrated and sutured in place. The wounds were examined on a weekly basis. One hundred percent healing was defined as complete reepithelialization (wound coverage). Results. Graftskin was well tolerated by these patients and resulted in complete wound healing within 9 weeks of application. Conclusion. Graftskin is an excellent alternative for difficult surgical wounds not amenable to other therapies. Graftskin results in a shortened healing time and decreased morbidity. It should be considered for wounds in which healing by secondary intention is preferably avoided.